Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Risk Assessment [NCBI]


Gene


Gene Link Information
Gain
01




OMIM


OMIM Link Information
gain
01
apnea, obstructive sleep [NCBI] 0.00229379
CRC [NCBI] 0.00193808
cluster headache, familial [NCBI] 0.00129281
KLK3 [NCBI] 0.0010791
FTSD [NCBI] 0.000777651
MGS [NCBI] 0.000777651
restless legs syndrome, susceptibility to, 3 [NCBI] 0.000678361
neutrophilic dermatosis, acute febrile [NCBI] 0.000528934
jejunal atresia [NCBI] 0.000528934
neuropathy, hereditary motor and sensory, russe type [NCBI] 0.000497713
TAPVR1 [NCBI] 0.000497713
FEB1 [NCBI] 0.000377358
lymphoma, non-hodgkin, familial [NCBI] 0.000336127
palatopharyngeal incompetence [NCBI] 0.000232694
MAFD2 [NCBI] 0.000201042
behcet syndrome [NCBI] 0.000196392
PCOS1 [NCBI] 0.000191895
SLE [NCBI] 0.000188332
klippel-trenaunay-weber syndrome [NCBI] 0.000175271
CJD [NCBI] 0.00011577
aortic valve disease [NCBI] 0.000115154
APOE [NCBI] 0.000108626
AFP [NCBI] 0.00010524
EGF [NCBI] 0.000101806
APC [NCBI] 9.41793e-05
CD [NCBI] 9.31674e-05
GIST [NCBI] 9.14827e-05
MG [NCBI] 8.82057e-05
FMF [NCBI] 8.0283e-05
LAM [NCBI] 7.5698e-05
PD [NCBI] 7.48493e-05
EPS [NCBI] 6.69219e-05
arteriovenous malformations of the brain [NCBI] 6.69219e-05
brugada syndrome 1 [NCBI] 6.40237e-05
HCRTR2 [NCBI] 6.33839e-05
thrombocytopenic purpura, autoimmune [NCBI] 5.67873e-05
FEB8 [NCBI] 5.66185e-05
diabetic nephropathy, susceptibility to [NCBI] 5.66185e-05
VRNI [NCBI] 5.62457e-05
RA [NCBI] 5.48436e-05
PNPLA6 [NCBI] 5.20713e-05
AHR [NCBI] 5.04228e-05
amyloidosis, familial visceral [NCBI] 4.99905e-05
pelizaeus-merzbacher-like disease, autosomal recessive, 1 [NCBI] 4.99905e-05
CMT4H [NCBI] 4.99905e-05
neuropathy, ataxia, and retinitis pigmentosa [NCBI] 4.99905e-05
cervical cancer [NCBI] 4.99905e-05
FA [NCBI] 4.90045e-05
CF [NCBI] 4.88663e-05
LSA [NCBI] 4.68753e-05
SMN1 [NCBI] 4.49656e-05
SMN2 [NCBI] 4.27896e-05
thrombophilia [NCBI] 4.12536e-05
AD [NCBI] 3.99423e-05
KCNH2 [NCBI] 3.83456e-05
twinning, monozygotic [NCBI] 3.80786e-05
PDV [NCBI] 3.80786e-05
avascular necrosis of femoral head, primary [NCBI] 3.80786e-05
danubian endemic familial nephropathy [NCBI] 3.72547e-05
BRCA2 [NCBI] 3.64927e-05
RNPEPL1 [NCBI] 3.54881e-05
COMT [NCBI] 3.54663e-05
CMT4B1 [NCBI] 3.53864e-05
IDDM [NCBI] 3.40101e-05
APOB [NCBI] 3.31659e-05
aspirin resistance [NCBI] 3.30552e-05
NIDDM1 [NCBI] 3.30552e-05
CMT4B2 [NCBI] 3.30552e-05
CMT4C [NCBI] 3.10043e-05
CMT4D [NCBI] 3.10043e-05
RP [NCBI] 3.09117e-05
VDR [NCBI] 3.06938e-05
3-@methylcrotonyl-coa carboxylase 1 deficiency [NCBI] 2.91772e-05
TS [NCBI] 2.88739e-05
HD [NCBI] 2.87882e-05
temporal arteritis [NCBI] 2.80159e-05
FABP2 [NCBI] 2.76973e-05
DA2B [NCBI] 2.75331e-05
CMT4A [NCBI] 2.75331e-05
GSTP1 [NCBI] 2.7309e-05
GPR35 [NCBI] 2.72558e-05
MTRNR1 [NCBI] 2.65714e-05
CPB2 [NCBI] 2.63836e-05
OPD1 [NCBI] 2.60413e-05
CRH [NCBI] 2.55082e-05
LQT1 [NCBI] 2.53489e-05
BRCA1 [NCBI] 2.48226e-05
TLR4 [NCBI] 2.46946e-05
HMN5 [NCBI] 2.46784e-05
TH [NCBI] 2.35079e-05
SOST [NCBI] 2.34259e-05
PALS [NCBI] 2.34259e-05
PCD [NCBI] 2.29084e-05
BCNS [NCBI] 2.25911e-05
ASPS [NCBI] 2.2269e-05
EGFR [NCBI] 2.22625e-05
CH25H [NCBI] 2.21517e-05
TCF7L2 [NCBI] 2.19899e-05
neuropathy, congenital hypomyelinating [NCBI] 2.11957e-05
FH [NCBI] 2.08869e-05
SH3TC2 [NCBI] 2.06638e-05
A2M [NCBI] 2.00821e-05
GFAP [NCBI] 1.98422e-05
GJC2 [NCBI] 1.94811e-05
GEFS+ [NCBI] 1.92624e-05
pancreatic carcinoma [NCBI] 1.92624e-05
alopecia, androgenetic [NCBI] 1.8921e-05
CEACAM5 [NCBI] 1.83943e-05
CCK [NCBI] 1.80706e-05
SHBG [NCBI] 1.75948e-05
LRRK2 [NCBI] 1.70911e-05
megaloblastic anemia 1 [NCBI] 1.67902e-05
PPARA [NCBI] 1.67192e-05
ALB [NCBI] 1.65797e-05
BDNF [NCBI] 1.6354e-05
TNNI2 [NCBI] 1.62851e-05
PWS [NCBI] 1.62354e-05
CBFB [NCBI] 1.57045e-05
GTS [NCBI] 1.54633e-05
CRMO [NCBI] 1.53674e-05
glycogen storage disease v [NCBI] 1.53674e-05
LBP [NCBI] 1.49194e-05
FDH [NCBI] 1.47121e-05
PDB [NCBI] 1.47121e-05
WWOX [NCBI] 1.46971e-05
NDRG1 [NCBI] 1.46971e-05
NRF1 [NCBI] 1.46971e-05
GARS [NCBI] 1.42543e-05
DRD1 [NCBI] 1.42543e-05
OLR1 [NCBI] 1.42543e-05
PTH [NCBI] 1.41646e-05
SMA2 [NCBI] 1.40903e-05
lung cancer [NCBI] 1.40903e-05
LCA1 [NCBI] 1.40903e-05
TNNI3 [NCBI] 1.38442e-05
NOTCH3 [NCBI] 1.38442e-05
PRX [NCBI] 1.38442e-05
MTMR2 [NCBI] 1.38442e-05
HABP2 [NCBI] 1.38442e-05
CCKAR [NCBI] 1.34626e-05
GDAP1 [NCBI] 1.34626e-05
THBD [NCBI] 1.31058e-05
ELAC2 [NCBI] 1.31058e-05
ALOX5 [NCBI] 1.31058e-05
DAR [NCBI] 1.29369e-05
KCNQ1OT1 [NCBI] 1.27709e-05
MEF2A [NCBI] 1.27709e-05
GABRG2 [NCBI] 1.27709e-05
DFSP [NCBI] 1.26653e-05
PAPPA [NCBI] 1.24555e-05
NF1 [NCBI] 1.24485e-05
PHB [NCBI] 1.18752e-05
PHOX2B [NCBI] 1.18752e-05
CHAT [NCBI] 1.17799e-05
CCND1 [NCBI] 1.16173e-05
FPLD2 [NCBI] 1.14016e-05
PCNA [NCBI] 1.13838e-05
HLA-DQB1 [NCBI] 1.13518e-05
BWS [NCBI] 1.12132e-05
CAPN10 [NCBI] 1.11083e-05
CASP8 [NCBI] 1.11083e-05
NR3C2 [NCBI] 1.11083e-05
AACT [NCBI] 1.11083e-05
periodic fever, familial, autosomal dominant [NCBI] 1.09349e-05
SLC25A20 [NCBI] 1.08757e-05
CRP [NCBI] 1.06529e-05
HLA-DRB1 [NCBI] 1.06529e-05
EGR2 [NCBI] 1.06529e-05
BMP15 [NCBI] 1.04393e-05
VEGF [NCBI] 1.01849e-05
PON1 [NCBI] 1.0117e-05
CMD1A [NCBI] 1.00611e-05
AVP [NCBI] 1.00503e-05
KL [NCBI] 1.00369e-05
RNASE3 [NCBI] 9.94596e-06
PBP [NCBI] 9.66397e-06
CADASIL [NCBI] 9.65157e-06
MBL2 [NCBI] 9.62149e-06
LEP [NCBI] 9.37256e-06
IL1A [NCBI] 9.31664e-06
IL18 [NCBI] 9.31664e-06
CETP [NCBI] 9.31664e-06
SMA3 [NCBI] 9.25886e-06
oca2 gene [NCBI] 9.1516e-06
MAOB [NCBI] 9.1516e-06
TNFRSF11B [NCBI] 9.13364e-06
PRL [NCBI] 9.06266e-06
TSD [NCBI] 8.64749e-06
ABCC6 [NCBI] 8.54162e-06
CHEK2 [NCBI] 8.26304e-06
RTT [NCBI] 7.93502e-06
GAA [NCBI] 7.87335e-06
hypophosphatemic rickets, x-linked dominant [NCBI] 7.83886e-06
panencephalitis, subacute sclerosing [NCBI] 7.772e-06
FOLH1 [NCBI] 7.75026e-06
ADIPOQ [NCBI] 7.63032e-06
DHFR [NCBI] 7.62577e-06
CDSP [NCBI] 7.51774e-06
MTATP6 [NCBI] 7.28801e-06
ALK [NCBI] 7.02559e-06
RTS [NCBI] 6.91159e-06
RP2 [NCBI] 6.8681e-06
HS [NCBI] 6.76897e-06
CAT [NCBI] 6.74288e-06
CSF3 [NCBI] 6.67199e-06
IS1 [NCBI] 6.43656e-06
NAT1 [NCBI] 6.21684e-06
MFS [NCBI] 6.15132e-06
HNF4A [NCBI] 5.88448e-06
HP [NCBI] 5.59174e-06
hypertrophic neuropathy of dejerine-sottas [NCBI] 5.5822e-06
glioma of brain, familial [NCBI] 5.5822e-06
MODY [NCBI] 5.52999e-06
GPT [NCBI] 5.43081e-06
AMC [NCBI] 5.11552e-06
DRD4 [NCBI] 5.08808e-06
VCP [NCBI] 5.02296e-06
FSHR [NCBI] 5.02296e-06
AMH [NCBI] 4.65617e-06
MDD [NCBI] 4.56883e-06
ACHE [NCBI] 4.48389e-06
MTHFR [NCBI] 4.42646e-06
PLN [NCBI] 4.26475e-06
NMB [NCBI] 4.21243e-06
NR1I2 [NCBI] 4.2046e-06
BL [NCBI] 4.19205e-06
homocystinuria [NCBI] 3.81985e-06
BCHE [NCBI] 3.7472e-06
PXE [NCBI] 3.72395e-06
CPI [NCBI] 3.57046e-06
GH1 [NCBI] 3.5527e-06
LMNA [NCBI] 3.51022e-06
KRT20 [NCBI] 3.4683e-06
ALD [NCBI] 3.45146e-06
SHH [NCBI] 3.44355e-06
PG [NCBI] 3.26667e-06
INS [NCBI] 3.25221e-06
prostate cancer [NCBI] 3.22734e-06
NRG1 [NCBI] 3.18956e-06
IFNA1 [NCBI] 3.11436e-06
polycystic kidneys [NCBI] 3.0542e-06
AS [NCBI] 3.0542e-06
PLAUR [NCBI] 3.00501e-06
HGPS [NCBI] 2.92467e-06
gaucher disease, type i [NCBI] 2.92467e-06
ATM [NCBI] 2.79796e-06
CFH [NCBI] 2.79796e-06
TPO [NCBI] 2.76002e-06
HBB [NCBI] 2.54189e-06
SLPI [NCBI] 2.39664e-06
glycogen storage disease ii [NCBI] 2.25794e-06
AVSD [NCBI] 2.13877e-06
ALS1 [NCBI] 2.13877e-06
UCP1 [NCBI] 2.10044e-06
AGER [NCBI] 2.02571e-06
ABCB1 [NCBI] 1.95337e-06
HGF [NCBI] 1.94658e-06
PGR [NCBI] 1.93985e-06
PSACH [NCBI] 1.91351e-06
VASP [NCBI] 1.88334e-06
IL6 [NCBI] 1.79339e-06
lynch syndrome i [NCBI] 1.70486e-06
ACADM [NCBI] 1.66544e-06
FGFR2 [NCBI] 1.64489e-06
PTK2 [NCBI] 1.64137e-06
breast cancer [NCBI] 1.60647e-06
ABP1 [NCBI] 1.60443e-06
PJS [NCBI] 1.57971e-06
TG [NCBI] 1.55866e-06
EPO [NCBI] 1.53941e-06
FRAP1 [NCBI] 1.45967e-06
ABCG2 [NCBI] 1.43247e-06
SMA1 [NCBI] 1.42104e-06
APP [NCBI] 1.39639e-06
PSORS1 [NCBI] 1.33379e-06
PF4 [NCBI] 1.2962e-06
NS1 [NCBI] 1.25006e-06
FTD [NCBI] 1.12644e-06
GRP [NCBI] 1.05929e-06
PMP22 [NCBI] 1.04498e-06
AIS [NCBI] 9.6547e-07
COMP [NCBI] 8.96976e-07
PRNP [NCBI] 8.71831e-07
GNRH1 [NCBI] 8.58206e-07
AR [NCBI] 7.96342e-07
CFTR [NCBI] 6.7644e-07
PLG [NCBI] 6.57477e-07
TNF [NCBI] 6.22877e-07
RB1 [NCBI] 5.88808e-07
G6PD [NCBI] 5.27123e-07
SMAX1 [NCBI] 5.15962e-07
SOD2 [NCBI] 4.50101e-07
MPO [NCBI] 4.01133e-07
ADA [NCBI] 3.91924e-07
TFPI [NCBI] 3.91183e-07
PMD [NCBI] 3.52407e-07
CD [NCBI] 3.23676e-07
CYP1A1 [NCBI] 2.84456e-07
TP53 [NCBI] 2.7945e-07
TNFSF6 [NCBI] 2.58475e-07
CTGF [NCBI] 2.39204e-07
SPP1 [NCBI] 1.44988e-07
ADHD [NCBI] 1.4417e-07
OPMD [NCBI] 1.4417e-07
TYMS [NCBI] 1.44155e-07
amyloidosis vi [NCBI] 1.4382e-07
ACE [NCBI] 1.26727e-07
CP [NCBI] 9.46449e-08
LRP1 [NCBI] 7.98971e-08
MB [NCBI] 6.60147e-08
PTHLH [NCBI] 6.18203e-08
LDLR [NCBI] 5.22521e-08
XDH [NCBI] 4.48554e-08
LPL [NCBI] 1.00765e-08
F3 [NCBI] 1.78417e-09
EV [NCBI] 5.42802e-10
MS [NCBI] 5.42802e-10
ACH [NCBI] 5.42802e-10




Database Center for Life Science